News2 mins ago
VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock
HENDERSON, Nev., June 5, 2023 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, announced today the closing of its previously announced underwritten public...
